NCT01090778View on ClinicalTrials.gov

Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Norditropin SimpleXx (growth hormone)

3mg/subject/day over two consecutive days

Trial Locations (2)

8000

Medical Department M, Aarhus University Hospital, Aarhus C

Aarhus University Hospital, Aarhus C

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Aarhus University Hospital

OTHER

NCT01090778 - Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I) | Biotech Hunter | Biotech Hunter